Concepedia

Camelia Quek

CQ

Statistics

Publications

33

Citations

5.1K

H-Index

23

Active since

2009

Affiliations

The University of Sydney(Current)

Melanoma Institute Australia

Royal Prince Alfred Hospital

Royal North Shore Hospital

The University of Melbourne

Camelia Quek is an author at The University of Sydney specializing in oncology, life sciences, and immunotherapy.

ORCID

Publications per year

2009–2025

33

Publications

33

FunRich: An open access standalone functional enrichment and interaction network analysis tool

Mohashin Pathan, Shivakumar Keerthikumar, Ching‐Seng Ang et al. · PROTEOMICS · 2015 · 1.4K citations

, , +17

Distinct Immune Cell Populations Define Response to Anti-PD-1 Monotherapy and Anti-PD-1/Anti-CTLA-4 Combined Therapy

Tuba N. Gide, Camelia Quek, Alexander M. Menzies et al. · Cancer Cell · 2019 · 1K citations · Full text

, , +17

Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade

Imran G. House, Peter Savas, Junyun Lai et al. · Clinical Cancer Research · 2019 · 766 citations

, , +17

CD103+ Tumor-Resident CD8+ T Cells Are Associated with Improved Survival in Immunotherapy-Naïve Melanoma Patients and Expand Significantly During Anti–PD-1 Treatment

Jarem Edwards, James S. Wilmott, Jason Madore et al. · Clinical Cancer Research · 2018 · 441 citations

, , +17

Site‐specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti–PD‐1 therapy

Inês Pires da Silva, Serigne Lo, Camelia Quek et al. · Cancer · 2019 · 165 citations · Full text

, , +17

1–5 of 33